Other Liabilities (Details) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2020
USD ($)
$ / shares
|
Jun. 30, 2020
USD ($)
item
$ / shares
|
Dec. 31, 2019
$ / shares
|
Sep. 25, 2018
shares
|
|
| Other Liabilities | ||||
| Exercise price | $ 1.00 | $ 1.00 | $ 1.00 | |
| Gain on revaluation of liability | $ | $ (232) | $ 41 | ||
| Warrants | ||||
| Other Liabilities | ||||
| Number of securities called by each warrant | shares | 13,062,878 | |||
| Exercise price | $ 0.01 | $ 0.01 | ||
| Number of warrants redeemable shares | item | 2 |
| X | ||||||||||
- Definition Number of warrants redeemable for each common share No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|